Solu Therapeutics Welcomes Enda Moran as New COO to Propel Innovative Therapies Forward Solu Therapeutics announces the appointment of Dr. Enda Moran as COO, aiming to enhance its innovative therapies targeting cancer and immunology.

Solu Therapeutics Welcomes Enda Moran as New COO to Propel Innovative Therapies Forward #United_States #Boston #cancer_therapies #Solu_Therapeutics #Enda_Moran